NIR‐II Organic Nanotheranostics for Precision Oncotherapy

Precision oncotherapy can remove tumors without causing any apparent iatrogenic damage or irreversible side effects to normal tissues. Second near‐infrared (NIR‐II) nanotheranostics can simultaneously perform diagnostic and therapeutic modalities in a single nanoplatform, which exhibits prominent pe...

Full description

Saved in:
Bibliographic Details
Published in:Small (Weinheim an der Bergstrasse, Germany) Germany), 2021-11, Vol.17 (44), p.e2102646-n/a
Main Authors: Dai, Hanming, Wang, Xiaorui, Shao, Jinjun, Wang, Wenjun, Mou, Xiaozhou, Dong, Xiaochen
Format: Article
Language:English
Subjects:
Biocompatibility
Humans
Nanotechnology
Near infrared radiation
Neoplasms - diagnosis
Neoplasms - therapy
organic nanotheranostics
Phototherapy
precision oncotherapy
Reproducibility of Results
second near‐infrared
Side effects
Theranostic Nanomedicine
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Precision oncotherapy can remove tumors without causing any apparent iatrogenic damage or irreversible side effects to normal tissues. Second near‐infrared (NIR‐II) nanotheranostics can simultaneously perform diagnostic and therapeutic modalities in a single nanoplatform, which exhibits prominent perspectives in tumor precision treatment. Among all NIR‐II nanotheranostics, NIR‐II organic nanotheranostics have shown an exceptional promise for translation in clinical tumor treatment than NIR‐II inorganic nanotheranostics in virtue of their good biocompatibility, excellent reproducibility, desirable excretion, and high biosafety. In this review, recent progress of NIR‐II organic nanotheranostics with the integration of tumor diagnosis and therapy is systematically summarized, focusing on the theranostic modes and performances. Furthermore, the current status quo, problems, and challenges are discussed, aiming to provide a certain guiding significance for the future development of NIR‐II organic nanotheranostics for precision oncotherapy. NIR‐II organic nanotheranostics can simultaneously perform diagnostic and therapeutic modalities in a single nanoplatform, which exhibits prominent perspectives in the early diagnosis and simultaneous precision treatment of cancer. Herein, the recent progress of NIR‐II organic nanotheranostics is systematically summarized, focusing on the theranostic modes and performances. Furthermore, the current status quo, problems, and challenges are analyzed.
ISSN:1613-6810
1613-6829
DOI:10.1002/smll.202102646